Search
for
Sort by
Research 871–900 of 1000+
- Efluvio anageno inducido por azatioprina: reporte de efecto adverso infrecuente
- Treatment of Chemotherapy Induced Alopecia
- Telogen effluvium after scalp Mohs micrographic surgery: a case report
- Female pattern hair loss
- Androgenetic Alopecia in Women: A Narrative Review of Pathophysiology, Clinical Evaluation, and Treatments
- Advancements in Bioactive Compounds and Therapeutic Agents for Alopecia: Trends and Future Perspectives
- Farmácia Central de Almada - Almada e nos Serviços Farmacêuticos do Hospital Garcia de Orta - Almada
- Management of Androgenetic Alopecia in Men in 2025: A Focused Review
- Male androgenetic alopecia
- Act Fast With Traction Alopecia to Avoid Permanent Hair Loss
- Androgenic alopecia and differential diagnoses of alopecia
- Revisión actualizada del tratamiento de la alopecia androgenética femenina
- Princípios ativos e procedimentos na Alopecia Androgenética
- Dermatologic therapy: December 1986 to December 1987
- Alopecia: evaluation and treatment
- The Treatment of Resistant Hypertension
- Expert consensus on the management of androgenetic alopecia in India
- Inhalation therapy for repairing damaged elastin fibers and decelerating elastinolysis in chronic obstructive pulmonary disease
- Natural products for male androgenetic alopecia
- The Ancient Remedies of Alopecia
- Formononetin: Novel Deal for Androgenetic Alopecia
- Scrotal Rejuvenation
- Addressing Androgenetic Alopecia-A Complex Disorder-with a Multilateral Treatment Strategy
- Androgenetic Alopecia
- Safety, tolerability, and pharmacokinetics of CG2001 in Chinese adult male subjects with androgenetic alopecia: a randomized, double-blind, placebo-controlled, single- and multi-doses, phase 1 clinical study
- Alopecia areata incognita: clinical characteristics and use of the Sinclair shedding scale
- Sponsored Lecture 3 : Updates on 5 alpha-rers(5ARIs) for the treatment of male pattern hair loss(MPHL)
- THE ROLE OF ESTROGEN IN WOMEN WITH ANDROGENETIC ALOPECIA
- Alopecia areata
- Prevention and management of dermatological toxicities related to anticancer agents: ESMO Clinical Practice Guidelines☆